tiprankstipranks
Advertisement
Advertisement

AU:NOX Stock Latest News

Noxopharm Preclinical Data Bolsters Sofra Immuno-Oncology Platform
Company AnnouncementsNoxopharm Preclinical Data Bolsters Sofra Immuno-Oncology Platform
1d ago
NOX
Noxopharm Data Validate TLR8-Targeted Oligonucleotide Cancer Strategy
PremiumCompany Announcements
Noxopharm Data Validate TLR8-Targeted Oligonucleotide Cancer Strategy
23d ago
NOX
Noxopharm advances Sofra platform as SOF-SKN nears FDA milestone
PremiumCompany Announcements
Noxopharm advances Sofra platform as SOF-SKN nears FDA milestone
1M ago
NOX
Noxopharm moves SOF-SKN toward U.S. FDA pathway to boost autoimmune portfolio
PremiumCompany Announcements
Noxopharm moves SOF-SKN toward U.S. FDA pathway to boost autoimmune portfolio
2M ago
NOX
Noxopharm Sofra Platform Backed in $1m Grant for Childbirth Injury Treatment
PremiumCompany Announcements
Noxopharm Sofra Platform Backed in $1m Grant for Childbirth Injury Treatment
2M ago
NOX
Noxopharm unveils human-like TLR8 model to accelerate cancer immunotherapy program
PremiumCompany AnnouncementsNoxopharm unveils human-like TLR8 model to accelerate cancer immunotherapy program
2M ago
NOX
Noxopharm Starts SOF-SKN Manufacturing Ahead of Cutaneous Lupus Trial
Premium
Company Announcements
Noxopharm Starts SOF-SKN Manufacturing Ahead of Cutaneous Lupus Trial
3M ago
NOX
Noxopharm Director Restructures Holding Via Off-Market Share Transfer
Premium
Company Announcements
Noxopharm Director Restructures Holding Via Off-Market Share Transfer
3M ago
NOX
Noxopharm Showcases Potent New TLR8-Based Immuno-Oncology Platform
PremiumCompany Announcements
Noxopharm Showcases Potent New TLR8-Based Immuno-Oncology Platform
3M ago
NOX
Noxopharm Plans CEO Option Grant Tied to Long-Term Share Price Growth
PremiumCompany Announcements
Noxopharm Plans CEO Option Grant Tied to Long-Term Share Price Growth
4M ago
NOX
Noxopharm Taps Novotech to Advance SOF-SKN Toward Key FDA Milestone
PremiumCompany Announcements
Noxopharm Taps Novotech to Advance SOF-SKN Toward Key FDA Milestone
4M ago
NOX
Noxopharm Data Backs SOF-16’s Anti-Inflammatory Potential in Autoimmune Disease
PremiumCompany Announcements
Noxopharm Data Backs SOF-16’s Anti-Inflammatory Potential in Autoimmune Disease
4M ago
NOX
Noxopharm Names CFO Shawn van Boheemen as New Company Secretary
PremiumCompany AnnouncementsNoxopharm Names CFO Shawn van Boheemen as New Company Secretary
4M ago
NOX
Noxopharm deepens Sofra push with Tezcat deal, CEO shift and key trial progress
Premium
Company Announcements
Noxopharm deepens Sofra push with Tezcat deal, CEO shift and key trial progress
4M ago
NOX
Noxopharm’s SOF-SKN shows prolonged skin retention in preclinical study
Premium
Company Announcements
Noxopharm’s SOF-SKN shows prolonged skin retention in preclinical study
4M ago
NOX
Noxopharm Tightens Disclosure Controls After CEO Resigns and Director Notices Updated
PremiumCompany Announcements
Noxopharm Tightens Disclosure Controls After CEO Resigns and Director Notices Updated
4M ago
NOX
Noxopharm CEO Resigns as Biotech Awaits Successor Amid Strategic Shift
PremiumCompany Announcements
Noxopharm CEO Resigns as Biotech Awaits Successor Amid Strategic Shift
5M ago
NOX
Noxopharm Half-Year Loss Widens as Net Tangible Assets Turn Negative
PremiumCompany Announcements
Noxopharm Half-Year Loss Widens as Net Tangible Assets Turn Negative
6M ago
NOX
Noxopharm Issues 15 Million New Shares Under Financing Facility
PremiumCompany Announcements
Noxopharm Issues 15 Million New Shares Under Financing Facility
6M ago
NOX
Noxopharm Issues 15 Million New Shares Under Financing Facility
PremiumCompany AnnouncementsNoxopharm Issues 15 Million New Shares Under Financing Facility
6M ago
NOX
Noxopharm Secures $2.8m R&D Rebate to Advance Sofra Clinical Programs
Premium
Company Announcements
Noxopharm Secures $2.8m R&D Rebate to Advance Sofra Clinical Programs
6M ago
NOX
Noxopharm Secures Flexible $5m At-the-Market Equity Facility with Acuity Capital
Premium
Company Announcements
Noxopharm Secures Flexible $5m At-the-Market Equity Facility with Acuity Capital
6M ago
NOX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >